Effect of Various Solvent Extracts of Annona Cherimola Mill Leaf Extract on Breast Cancer Cell Line MCF-7

Main Article Content

Lokeshvar R.
Ramaiyan Velmurugan
Kishan Kumar S. B.
Tamilanban D.
Sandhiya V.
Tamizharasi S.
Keerthana R.
Aravindhan T.
Mahalakshmi D.


Background: In the last few years, various research has focused on the potential of herbal medicines as an alternative therapy for cancer. This is due in large part to the fact that these medications have very few side effects on healthy cells. Cherimoya, or Annona cherimola mill, is a natural fruit that is edible and recognized to exhibit several biological functions due to its significant content of phytochemical components. The anti-cancer effects of A. cherimola ethanolic leaf extract on leukemia have been described in previous investigations. The purpose of this in-vitro research is to investigate the possible anti-cancer efficacy of several solvent extracts of Annona cherimola mill in breast cancer cell lines, namely MCF-7. Methods: Cell viability assays were used to assess the antiproliferative effects of different solvent extracts. The purpose of this study was to analyze the aqueous extract of A.cherimola mill for cell viability, cell cycle, apoptosis detection, intracellular reactive oxygen species measurement, and protein characterization using western blotting. Results: Cell viability was reduced by 47% treated with aqueous extract, demonstrating its selectivity for the line of breast cancer cells. MCF-7. The IC25 for the extract was 0.43 mg/ml (MCF-7). Conclusion: Our findings reveal that the aqueous extract of A. cherimola mill has anti-tumor properties by selectively inhibiting the breast cancer cells (MCF-7) and promoting their apoptosis.

Article Details

How to Cite
Lokeshvar R., Velmurugan, R. ., Kumar S. B., K. ., Tamilanban D., Sandhiya V., Tamizharasi S., Keerthana R., Aravindhan T., & Mahalakshmi D. (2023). Effect of Various Solvent Extracts of Annona Cherimola Mill Leaf Extract on Breast Cancer Cell Line MCF-7. Journal of Coastal Life Medicine, 11(1), 1865 –. Retrieved from https://jclmm.com/index.php/journal/article/view/597


Egea I, Sánchez-Bel P, Romojaro F, Pretel MT. Six edible wild fruits as potential antioxidant additives or nutritional supplements. Plant Foods Hum Nutr. 2010; 65:1219.

Gurib-Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Asp Med. 2006; 27:1–93.

Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci. 2005; 78:431–41.

van Wyk B-E, Wink M. Medicinal Plants of the World. CABI; 2018.

Priya ML, Priya KB, Kotakadi VS, Josthna P. Herbal and Medicinal Plants Molecules Towards Treatment of Cancer: A Mini Review. Am J Ethnomedicine. 2015; 2:136–42.

Rani P, Khullar N. Antimicrobial evaluation of some medicinal plants for their anti-enteric potential against multi-drug resistant Salmonella typhi. Phytother Res. 2004;18:670–3.

Pumiputavon K, Chaowasku T, Saenjum C, Osathanunkul M, Wungsintaweekul B, Chawansuntati K, et al. Cytotoxic and cytostatic effects of four Annonaceae plants on human cancer cell lines. In Vitro Cell Dev Biol Anim. 2019; 55:723–32.

Pumiputavon K, Chaowasku T, Saenjum C, Osathanunkul M, Wungsintaweekul B, Chawansuntati K, et al. Cell cycle arrest and apoptosis induction by methanolic leaves extracts of four Annonaceae plants. BMC Complement Altern Med. 2017; 17:1–11.

Attiq A, Jalil J, Husain K. Annonaceae: breaking the wall of inflammation. Front Pharmacol. 2017; 8:752.

Xu F. Ronse De Craene L. floral ontogeny of Annonaceae: evidence for high variability in floral form. Ann Bot. 2010; 106:591–605.

Nugraha AS, Damayanti YD, Wangchuk P, Keller PA. Anti-infective and anti-Cancer properties of the Annona species: their Ethnomedicinal uses, alkaloid diversity, and Pharmacological activities. Molecules. 2019; 24:4419.

Bories C, Loiseau P, Cortes D, Myint SH, Hocquemiller R, Gayral P, et al. Antiparasitic activity of Annona muricata and Annona cherimolia seeds. Planta Med. 1991; 57:434–6.

Ishola IO, Awodele O, Olusayero AM, Ochieng CO. Mechanisms of analgesic and anti-inflammatory properties of Annona muricata Linn. (Annonaceae) fruit extract in rodents. J Med Food. 2014; 17:1375–82.

Yang C, Gundala SR, Mukkavilli R, Vangala S, Reid MD, Aneja R. Synergistic interactions among flavonoids and acetogenins in Graviola (Annona muricata) leaves confer protection against prostate cancer. Carcinogenesis. 2015; 36:656–65.

Paull RE, Duarte O. Tropical fruits. 2nd ed. Wallingford, UK. Cambridge: CABI; 2011.

Pardhasaradhi BVV, Reddy M, Ali AM, Kumari AL, Khar A. Differential cytotoxic effects ofAnnona squamosa seed extracts on human tumor cell lines: role of reactive oxygen species and glutathione. J Biosci. 2005; 30:237–44.

Albuquerque TG, Santos F, Sanches-Silva A, Beatriz Oliveira M, Bento AC, Costa HS. Nutritional and phytochemical composition of Annona cherimola mill. Fruits and by-products: potential health benefits. Food Chem. 2016;193: 187–95.

Varadharaj V PA. Phytochemical and pharmacological potential of Annona species: a review. Asian J Pharm Clin Res. 2017:68–75.

Haykal T, Nasr P, Hodroj MH, Taleb RI, Sarkis R, MNEl M, et al. Annona cherimola Seed Extract Activates Extrinsic and Intrinsic Apoptotic Pathways in Leukemic Cells. Toxins. 2019; 11:506.

Arunjyothi B, Venkatesh K, Chakrapani P, Anupalli RR. Phytochemical and Pharmacological potential of Annona cherimola-A Review. Int J Phytomedicine. 2012; 3:439–47.

Ammoury C, Younes M, El Khoury M, Hodroj MH, Haykal T, Nasr P, et al. The pro-apoptotic effect of a Terpene-rich Annona cherimola leaf extract on leukemic cell lines. BMC Complement Altern Med. 2019; 19:365.

Nounou MI, ElAmrawy F, Ahmed N, Abdelraouf K, Goda S, Syed-Sha-Qhattal H. Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies. Breast Cancer Basic Clin Res. 2015;9s2: BCBCR.S29420.

Akram M, Iqbal M, Daniyal M, Khan AU. Awareness and current knowledge of breast cancer. Biol Res. 2017; 50:33.

Kim JY, Dao TTP, Song K, Park SB, Jang H, Park MK, et al. Annona muricata leaf extract triggered intrinsic apoptotic pathway to attenuate cancerous features of triple negative breast Cancer MDA-MB-231 cells. Evid Based Complement Alternat Med. 2018; 2018:1–10.

Greenwell M, Rahman PKSM. Medicinal plants: their use in anticancer treatment. Int J Pharm Sci Res. 2015; 6:4103–12.

Arunjyothi, B.; Venkatesh, K.; Chakrapani, P.; Anupalli, R.R. Phytochemical and Pharmacological potential of Annona cherimola- A Review. Int. J. Phytomed. 2011; 3: 439.

Hunakova L, Sedlakova O, Cholujova D, Gronesova P, Duraj J, et al. Modulation of markers associated with aggressive phenotype in MDA-MB-231 breast carcinoma cells by sulforaphane. Neoplasma. 2009; 56: 548-556.

Mladkova J, Sanda M, Matouskova E, Selicharova I. Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins. Bmc Cancer. 2010; 10.

Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nature Reviews Drug Discovery. 2009; 8: 579-591.

Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Molecular and Cellular Biochemistry. 2004; 266: 37-56.

Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. Journal of Molecular Medicine- Jmm. 1996; 74: 297-312.

Sinha RP, Hader DP. UV-induced DNA damage and repair: a review. Photochemical & Photobiological Sciences. 2002; 1: 225-236.

Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA. DNA repair pathways as targets for cancer therapy. Nature Reviews Cancer. 2008; 8: 193-204.

Hu H, Ahn N-S, Yang X, Lee Y-S, Kang K-S. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. International Journal of Cancer. 2002; 102: 250-253.

Qu XP, Yu J, Bhagat G, Furuya N, Hibshoosh H, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. Journal of Clinical Investigation. 2003; 112: 1809-1820.

Geyer RK, Yu ZK, Maki CG. The MDM2 RING- finger domain is required to promote p53 nuclear export. Nature Cell Biology. 2000; 2: 569-573.